#gcpharma — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #gcpharma, aggregated by home.social.
-
GC Holdings' Chairman Heo Il-seop acquires 40,000 shares, increasing stake to 12.28%, while GC Pharma's Director Heo Eun-chul purchases 23,107 shares, raising ownership to 2.68%
#YonhapInfomax #GCHoldings #ShareAcquisition #ChairmanHeoIlSeop #OwnershipStake #GCPharma #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60473 -
GC Holdings' Chairman Heo Il-seop acquires 40,000 shares, increasing stake to 12.28%, while GC Pharma's Director Heo Eun-chul purchases 23,107 shares, raising ownership to 2.68%
#YonhapInfomax #GCHoldings #ShareAcquisition #ChairmanHeoIlSeop #OwnershipStake #GCPharma #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60473 -
GC Holdings' Chairman Heo Il-seop acquires 40,000 shares, increasing stake to 12.28%, while GC Pharma's Director Heo Eun-chul purchases 23,107 shares, raising ownership to 2.68%
#YonhapInfomax #GCHoldings #ShareAcquisition #ChairmanHeoIlSeop #OwnershipStake #GCPharma #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60473 -
GC Holdings' Chairman Heo Il-seop acquires 40,000 shares, increasing stake to 12.28%, while GC Pharma's Director Heo Eun-chul purchases 23,107 shares, raising ownership to 2.68%
#YonhapInfomax #GCHoldings #ShareAcquisition #ChairmanHeoIlSeop #OwnershipStake #GCPharma #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60473 -
GC Pharma selected for KDCA's mRNA vaccine development project, aiming to secure domestic platform with 505.2 billion won investment by 2028
#YonhapInfomax #GCPharma #MRNAVaccine #KDCA #VaccineDevelopment #PandemicPreparedness #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=59197 -
GC Pharma's US affiliate Curevo Vaccine secures $110 million in Series B funding for shingles vaccine development, led by European VC Medicxi with participation from major healthcare investors.
#YonhapInfomax #CurevoVaccine #SeriesBFunding #ShinglesVaccine #GCPharma #ClinicalTrials #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=54474